4.240
-0.030
(-0.70%)
At close: April 17 at 4:08:07 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,272,327
3,172,048
2,830,088
2,955,172
2,190,208
Cost of Revenue
1,524,962
1,471,355
1,446,782
1,404,521
1,100,220
Gross Profit
1,747,365
1,700,693
1,383,306
1,550,651
1,089,988
Operating Expense
1,199,188
1,161,336
1,074,244
1,070,894
800,588
Operating Income
548,177
539,357
309,062
479,757
289,400
Net Non Operating Interest Income Expense
-41,060
-39,334
-25,148
-21,904
-32,444
Pretax Income
517,720
509,588
290,146
464,087
124,224
Tax Provision
111,464
107,411
69,597
103,712
16,565
Net Income Common Stockholders
408,150
404,102
220,458
360,825
107,763
Diluted NI Available to Com Stockholders
408,150
404,102
220,458
360,825
107,763
Basic EPS
0.43
0.42
0.23
0.38
0.11
Diluted EPS
0.43
0.42
0.23
0.38
0.11
Basic Average Shares
951,287.372
951,970.289
956,038.265
957,223.602
961,914.338
Diluted Average Shares
951,287.372
951,970.289
956,038.265
957,223.602
961,914.338
Rent Expense Supplemental
10,734
11,435
10,256
--
--
Total Expenses
2,724,150
2,632,691
2,521,026
2,475,415
1,900,808
Net Income from Continuing & Discontinued Operation
408,150
404,102
220,458
360,825
107,763
Normalized Income
407,518.315
403,502.360
220,458
360,825
386,740.737
Interest Income
5,085
1,888
1,122
1,157
1,255
Interest Expense
45,726
40,742
24,333
20,097
29,825
Net Interest Income
-41,060
-39,334
-25,148
-21,904
-32,444
EBIT
563,446
550,330
314,479
484,184
154,049
EBITDA
704,954
695,879
462,536
624,586
289,800
Reconciled Cost of Revenue
1,524,962
1,471,355
1,446,782
1,404,521
1,100,220
Reconciled Depreciation
141,508
145,549
148,057
140,402
135,751
Net Income from Continuing Operation Net Minority Interest
408,150
404,102
220,458
360,825
107,763
Total Unusual Items Excluding Goodwill
805
760
--
--
-148,611
Total Unusual Items
805
760
--
--
1,521
Normalized EBITDA
704,149
695,119
462,536
624,586
288,279
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
173.315
160.360
--
--
-19,765.263
12/31/2020 - 12/15/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7716.T Nakanishi Inc.
1,812.00
+1.91%
SRT0.F Sartorius Aktiengesellschaft
42.40
+1.92%
SYNSAM.ST Synsam AB (publ)
44.40
-1.99%
SRT.SG Sartorius AG
171.60
+1.66%
BONEX.ST Bonesupport Holding AB (publ)
309.40
-2.46%
AFX.DE Carl Zeiss Meditec AG
56.60
-1.91%
NVST Envista Holdings Corporation
15.18
+1.07%
COLO-B.CO Coloplast A/S
702.40
+0.03%
STMN.SW Straumann Holding AG
96.92
+1.49%
STAA STAAR Surgical Company
16.89
+4.65%